Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.


Alzheimer's Disease

(Alzheimer's Dementia)
Definition

Alzheimer's disease is a progressive condition that destroys brain cells. It is the most common cause of dementia . People with this disease slowly lose the ability to learn, function, and remember.

Causes

The cause is not yet known. Studies suggest that two main mechanisms are involved with the development of Alzheimer's disease:

  • Neurofibrillary tangles—twisted fibers (called tau fibers) within nerve cells
  • Plaques—abnormal deposits of a substance called beta amyloid in different areas of the brain
Risk Factors

Factors that may increase your chance of Alzheimer's disease include:

  • Age: 65 and older
  • Depression
  • Down's syndrome
  • Down's syndrome in a first-degree relative
  • Elevated levels of homocysteine
  • Family history of Alzheimer's disease
  • Heart disease
  • Lower educational achievement
  • Presence of a certain variety type of protein (APOE-e4)
  • Previous serious, traumatic brain injury
  • Smoking
  • Women under 35 who give birth to a child with Down's syndrome

Researchers are studying the following to see if they are related to Alzheimer's disease:

  • Certain viral infections
  • Diabetes
  • Excess metal in the blood, especially zinc, copper, aluminum, and iron
  • High Cholesterol
  • Poor nutrition and vitamin deficiency in childhood
Symptoms

The disease begins as mild memory lapses. It moves to profound loss of memory and function. Alzheimer's disease is divided into three stages:

  • Early—memory and cognition loss are noticeable but still able to function independently
  • Intermediate—mental loss, personality changes more dependent on others for basic needs
  • Severe—loss of personality and bodily functions; total dependence for care

Symptoms include:

  • Increasing trouble remembering things, such as:
    • How to do simple math
    • How to do usual tasks, such as cooking, dressing, bathing, etc.
    • How to get to familiar locations
    • What the names of family and friends are
    • Where common objects are usually kept
  • Being withdrawn, losing interest in usual activities
  • Forgetting the date, time of day, season
  • Getting lost in familiar surroundings
  • Having difficulty completing sentences due to lost/forgotten words (may progress to complete inability to speak)
  • Having difficulty concentrating on tasks
  • Having mood swings
  • Having personality changes
  • Having poor coordination
  • Losing purposeful movement
  • Walking in a slow, shuffling way
Diagnosis

There are no tests to definitively diagnose this disease. The doctor will ask about your symptoms and medical history. A physical exam will be done. The doctor will ask many questions. This will help to rule out other causes.

Tests to rule out other medical conditions may include:

  • Blood tests and urine tests
  • CT scan —a type of x-ray that uses a computer to make pictures of the brain
  • Electroencephalogram (EEG) —a test that measures electrical currents in the brain
  • Lumbar puncture —to test for levels of certain brain proteins that increase with Alzheimer’s disease and to rule out other disorders
  • MRI scan —a test that uses magnetic waves to make pictures of the brain
  • Neurological exam
  • PET scan of the brain—a test that makes images showing activity in the brain
  • Psychological and mental status testing
Treatment

There is no cure for Alzheimer's disease. There are also no certain ways to slow its progression. Four medicines have received approval for the treatment of some symptoms. Various drugs are being studied to see if they can manage the symptoms or slow the condition's course.

Medications for Symptoms and Disease Progression

Only two types of medicines have been approved to reduce the symptoms of Alzheimer's disease:

  • Cholinesterase inhibitors—approved and recommended for mild to moderate Alzheimer's disease (eg, donepezil [Aricept], rivastigmine [Exelon], galantamine [Reminyl])
  • N-methyl-D-aspartate (NMDA) receptor antagonist—approved for moderate to severe Alzheimer's disease (eg, memantine )

Treatments that are being studied include:

  • Herbs and supplements (eg, vitamin E , ginkgo biloba )—The evidence is mixed as to the effectiveness of these natural remedies.
  • Gamma-secretase inhibitors
  • Tau fiber aggregation inhibitors
Lifestyle Management

Managing the disease includes:

  • Creating an environment in which you can receive the care you need
  • Encouraging family and close friends to visit frequently
  • Helping yourself learn to deal with the frustration of your uncontrollable behavior
  • Keeping yourself safe
  • Light, appropriate exercise to reduce agitation and relieve depression
  • Optimizing your quality of life
  • Playing quiet music
  • Providing a calm, quiet, predictable environment
  • Providing appropriate eyewear and hearing aids, easy-to-read clocks and calendars
Psychiatric Medication

Psychiatric symptoms may occur with Alzheimer’s disease. Your doctor may prescribe medicine to treat:

  • Anxiety
  • Confusion, paranoia, and hallucinations
  • Depression
Caregiver Support

Caring for a person with Alzheimer's disease is extremely difficult and exhausting. The primary caregiver needs emotional support, as well as regular respite.

If you are diagnosed with Alzheimer's disease, follow your doctor's instructions.

Prevention

There are no guidelines for preventing Alzheimer's disease because the cause is unknown.

Last reviewed: September 2011 by Rimas Lukas, MD.

RESOURCES:
CANADIAN RESOURCES:
References:
  • Alzheimer's disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/what.php . Updated October 2009. Accessed January 8, 2010.
  • Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: http://www.nia.nih.gov/Alzheimers/Publications/medicationsfs.htm . Updated September 2009. Accessed January 8, 2010.
  • Alzheimer's disease and non-Alzheimer’s dementia. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/healthLibrary/ . Updated September 2009. Accessed January 8, 2010.
  • American Academy of Neurology website. Available at: http://www.aan.com/professionals/ . Accessed October 12, 2005.
  • Carillo MC, Blackwell A, Hampel H, et al. Early risk assessment for Alzheimer's disease. Alzheimers Dement . 2009;5(2):182-196.
  • Dementia. EBSCO Health Library website. Available at: http://www.ebscohost.com/healthLibrary/ . Updated November 2009. Accessed January 8, 2010.
  • Deweerdt S. Prevention: activity is the best medicine. Nature . 2011;475:S16-S17.
  • Goetz CG. Textbook of Clinical Neurology . Philadelphia, PA: WB Saunders Company; 1999.
  • Green RC, Cupples LA, Go R, et al. Risk of dementia among white and African-American relatives of patients with Alzheimer disease. JAMA . 2002;287:329-336.
  • Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov . 2010;9:560-574.
  • Hayden KM, Welsh-Bohmer KA. Epidemiology of cognitive aging and Alzheimer’s disease: contributions of the Cache County Utah study of memory, health, and aging. Curr Top Behav Neurosci . 2011 Aug 2.
  • Kasper DL, Braunwald E, Fauci AS, et al. Harrison's Principles of Internal Medicine . 16th ed. New York, NY: The McGraw-Hill Companies; 2005.
  • Neugroschl J, Sano M. An update on treatment and prevention strategies for Alzheimer’s disease. Curr Neurol Neurosci Rep . 2009;9:368-376.
  • Rakel RE, Bope ET. Conn's Current Therapy . 53rd ed. Philadelphia, PA: WB Saunders Company; 2001.
  • Rowland LP, Merritt HH. Alzheimer's disease and related dementias. Merritt's Neurology . Philadelphia, PA: Lippincott Williams and Wilkins; 2000: chap 106.
  • 1/8/2010 DynaMed's Systematic Literature Surveillance DynaMed's Systematic Literature Surveillance : Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA . 2009;302:2663-2670.